ARCHIVES

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

This article is from The Cancer Letter archive.

Vol. 09 No. 15 | April 15, 1983

Download PDF Visit The Full Archive

Related Articles

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Martha Fewell, Assistant To NCI Directors, To Retire

May 3, 2002

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014